ZILICO LIMITED

Active Swallownest

Manufacture of medical and dental instruments and supplies

0 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and suppliesSpecialists medical practice activities
Z

ZILICO LIMITED

Manufacture of medical and dental instruments and supplies

Founded 28 Feb 2006 Active Swallownest, England 0 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and suppliesSpecialists medical practice activities

Previous Company Names

APERIO DIAGNOSTIC LIMITED 27 Mar 2006 — 17 Jul 2008
GAG236 LIMITED 28 Feb 2006 — 27 Mar 2006
Accounts Submitted 2 Oct 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 6 Mar 2026 Next due 14 Mar 2027 10 months remaining
Net assets £-38K £100K 2024 year on year
Total assets £310K £12K 2024 year on year
Total Liabilities £349K £112K 2024 year on year
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

59 Cirrus Business Services Limited 59 Chesterfield Road Swallownest S26 4TL England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ZILICO LIMITED (05724284), an active life sciences and medical technology company based in Swallownest, England. Incorporated 28 Feb 2006. Manufacture of medical and dental instruments and supplies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£23.03k

Increased by £17.51k (+317%)

Net Assets

-£38.49k

Decreased by £100.36k (-162%)

Total Liabilities

£348.58k

Increased by £112.26k (+48%)

Turnover

N/A

Employees

N/A

Decreased by 3 (-100%)

Debt Ratio

112%

Increased by 33 (+42%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

84 Allotments 13,061,230 Shares £1291435.58m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
6 Mar 202626,411£18k£0.7
16 Feb 202623,142£16k£0.7
7 Jul 202521,356£15k£0.7
6 Jun 202550,713£35k£0.7
10 Apr 2025136,623£96k£0.7

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (142)

Kcp Nominees Ltd
50.0%
7,530,584
Nwf (biomedical) Lp
6.2%
931,862

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Kcp Nominees Limited

United Kingdom

Active
Notified 26 Feb 2021
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Spark Impact Limited

Ceased 27 Feb 2018

Ceased

Reyker Securities Plc

Ceased 26 Feb 2021

Ceased

Group Structure

Group Structure

BAND BIDCO LIMITED united kingdom
KIN GROUP LIMITED united kingdom
KCP NOMINEES LTD united kingdom
ZILICO LIMITED Current Company

Charges

Charges

2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Mar 2026CapitalAllotment of shares (GBP 2,149,844.1446) on 2026-03-25
6 Mar 2026Confirmation StatementConfirmation statement made on 2026-02-28 with updates
6 Mar 2026CapitalAllotment of shares (GBP 2,149,834.2147) on 2026-03-06
16 Feb 2026CapitalAllotment of shares (GBP 2,149,831.5736) on 2026-02-16
13 Jan 2026OfficersTermination of James William Thurlow as director on 2025-12-22
27 Mar 2026 Capital

Allotment of shares (GBP 2,149,844.1446) on 2026-03-25

6 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-02-28 with updates

6 Mar 2026 Capital

Allotment of shares (GBP 2,149,834.2147) on 2026-03-06

16 Feb 2026 Capital

Allotment of shares (GBP 2,149,831.5736) on 2026-02-16

13 Jan 2026 Officers

Termination of James William Thurlow as director on 2025-12-22

Recent Activity

Latest Activity

Allotment of shares (GBP 2,149,844.1446) on 2026-03-25

3 weeks ago on 27 Mar 2026

Confirmation statement made on 2026-02-28 with updates

1 months ago on 6 Mar 2026

Allotment of shares (GBP 2,149,834.2147) on 2026-03-06

1 months ago on 6 Mar 2026

Allotment of shares (GBP 2,149,831.5736) on 2026-02-16

2 months ago on 16 Feb 2026

Termination of James William Thurlow as director on 2025-12-22

3 months ago on 13 Jan 2026